NEW YORK (GenomeWeb) – Baby Genes plans to expand conventional metabolic newborn screening with targeted genetic testing in order to provide faster definite diagnoses.

The Golden, Colorado-based startup recently launched a next-gen sequencing newborn screening panel, targeting 89 genes that have been linked to more than 60 metabolic conditions. It has been offering the assay for $330 and with a turnaround time of 96 hours or less as a reflex or diagnostic test, a supplemental newborn screening test, or a carrier screening test.